Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vermeire

Showing results (31-40 of 137) with videos related to

Pageof 14
Sort By:
Inflammatory Bowel Diseases|August 24, 2005
Saccharomyces boulardii in Crohn's disease: effect on anti-Saccharomyces cerevisiae antibodies and intestinal permeabilityS Joossens, P Suenaert, M Noman, et al.
Gut|May 16, 2006
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsJ Satsangi, M S Silverberg, S Vermeire, et al.
Acta Gastro-Enterologica Belgica|December 15, 2020
Membranous colitis: a potentially bone-deep diagnosisM Bronswijk, T Ieven, R Schrijvers, et al.
Acta Gastro-Enterologica Belgica|February 26, 2023
A curious presentation of Crohn's disease with pulmonary involvement: a case reportS Haenen, B Verstockt, M Ferrante, et al.
International Journal of Oral and Maxillofacial Surgery|August 31, 2019
Osteonecrosis of the jaw in patients with inflammatory bowel disease treated with tumour necrosis factor alpha inhibitorsK Brijs, I Miclotte, S Vermeire, et al.
Scandinavian Journal of Gastroenterology|August 17, 2021
Long-term clinical outcome after thiopurine discontinuation in elderly IBD patientsC Jorissen, B Verstockt, N Schils, et al.
The American Journal of Gastroenterology|March 31, 2001
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseaseM Peeters, S Joossens, S Vermeire, et al.
Acta Gastro-Enterologica Belgica|April 2, 2020
Quality of care in an inflammatory bowel disease clinical trial center : a prospective study evaluating patients' satisfactionS Coenen, M Haeck, M Ferrante, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2012
Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapyT Bessissow, M Renard, I Hoffman, et al.
Acta Clinica Belgica|January 12, 2005
Management of ulcerative colitis and Crohn's diseaseF Baert, S Vermeire, M Noman, et al.
Pageof 14

Showing results (31-40 of 137) with videos related to

Sort By:
Pageof 14
Inflammatory Bowel Diseases|August 24, 2005
Saccharomyces boulardii in Crohn's disease: effect on anti-Saccharomyces cerevisiae antibodies and intestinal permeabilityS Joossens, P Suenaert, M Noman, et al.
Gut|May 16, 2006
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsJ Satsangi, M S Silverberg, S Vermeire, et al.
Acta Gastro-Enterologica Belgica|December 15, 2020
Membranous colitis: a potentially bone-deep diagnosisM Bronswijk, T Ieven, R Schrijvers, et al.
Acta Gastro-Enterologica Belgica|February 26, 2023
A curious presentation of Crohn's disease with pulmonary involvement: a case reportS Haenen, B Verstockt, M Ferrante, et al.
International Journal of Oral and Maxillofacial Surgery|August 31, 2019
Osteonecrosis of the jaw in patients with inflammatory bowel disease treated with tumour necrosis factor alpha inhibitorsK Brijs, I Miclotte, S Vermeire, et al.
Scandinavian Journal of Gastroenterology|August 17, 2021
Long-term clinical outcome after thiopurine discontinuation in elderly IBD patientsC Jorissen, B Verstockt, N Schils, et al.
The American Journal of Gastroenterology|March 31, 2001
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseaseM Peeters, S Joossens, S Vermeire, et al.
Acta Gastro-Enterologica Belgica|April 2, 2020
Quality of care in an inflammatory bowel disease clinical trial center : a prospective study evaluating patients' satisfactionS Coenen, M Haeck, M Ferrante, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2012
Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapyT Bessissow, M Renard, I Hoffman, et al.
Acta Clinica Belgica|January 12, 2005
Management of ulcerative colitis and Crohn's diseaseF Baert, S Vermeire, M Noman, et al.
Pageof 14